• Members Area (login)
  • Contact Us
  • Twitter
  • LinkedIn
Pharmabiotic Research Institute (PRI)
    • PRI
      • Home
      • Purpose & People
      • Representation
      • Partnerships
      • Task Groups
      • Members
      • Pharmabiotics Conference
      • Join PRI
    • Microbiome
      • Microbiome Science
      • Regulatory Status
      • Microbiome-based Medicinal Products
    • Regulatory Science
      • EU Landscape
      • Regulatory Framework
      • Regulatory Science & Tools
    • Insights
      • News & Events
      • PRI Publications
      • Member Job Openings
      • Members Area
Select Page
Galileo Research

Galileo Research

by Camille Bello | Nov 25, 2025 | Microbiome Pre-Clinical Research (CRO), Microbiome Clinical Research (CRO)

Silvia Trasciatti Chief Scientific Officer Galileo Research is specialized in non-clinical Discovery and Development services for the LifeSciences sector. Their expertise empowers companies in the pharmaceutical, medical device,novel foods, and dietary supplements...
BYOME LABS

BYOME LABS

by Camille Bello | Nov 25, 2025 | Microbiome Analysis Expertise (service provider), Diagnostics

David Suissa CEO and Founder BYOME LABS is a French deep-tech startup specializing in in vitro microbiome analysis applied to cosmetics, dermocosmetics and pharmaceuticals. The company works with finished-product brands, ingredient manufacturers and retailers to help...
Ewha Womans University

Ewha Womans University

by Camille Bello | Sep 16, 2025 | Microbiome Research & Technology (public)

Sunwha Park M.D., Ph.D. Board-certified obstetrician-gynecologist and Clinical Assistant Professor Dr. Sunwha Park, MD, PhD, is an obstetrician-gynecologist and maternal-fetal medicine specialist at Ewha Womans University Medical Center, where she is Clinical...
BiomeBank

BiomeBank

by Camille Bello | Aug 28, 2025 | Microbiome Product Developer, Microbiome Research & Technology (public)

Jo Close Chief Operating Officer BiomeBank is building the future of microbial medicine, grounded in proven science and engineered for what the world needs next. The company has already delivered the first approved donor-derived microbiome drug for recurrent...
University of Zagreb, School of Medicine

University of Zagreb, School of Medicine

by Camille Bello | Jun 26, 2025 | Microbiome Research & Technology (public)

Mihaela Perić Senior Research Associate The Department for Intercellular Communication is part of the Center for Translational and Clinical Research, University of Zagreb School of Medicine. The Department was established within the academic community as a branch of...
« Older Entries

Recent News & Events

  • Shaping the future of European biotechnology: PRI’s response to the EU Biotech Act Call for Evidence
  • PRI welcomes Camille Bello as Communication and Membership Manager
  • PRI Board of Director members elects Eleni Tsompanidou as New President
  • Microbiome-based Biomarkers – a multidisciplinary Delphi consensus (The Lancet Microbe)
  • 2024 Pharmabiotics Conference & Partnering – Lille

– Legal Notices –
© PRI 2022. All rights reserved. Copy prohibited unless explicitly authorized. Please contact the PRI.

Pharmabiotic Research Institute (PRI) | European Microbiome Regulatory Science Center
Non-Profit Association (loi 1901) – 1 bis, rue Sénateur Emile Roux, 11100 Narbonne, France

Agence de communication : Frelonbleu